Literature DB >> 28090009

Prognostic Impact of Atrial Fibrillation and New Risk Score of Its Onset in Patients at High Risk of Heart Failure - A Report From the CHART-2 Study.

Takeshi Yamauchi1, Yasuhiko Sakata, Masanobu Miura, Takeo Onose, Kanako Tsuji, Ruri Abe, Takuya Oikawa, Shintaro Kasahara, Masayuki Sato, Kotaro Nochioka, Takashi Shiroto, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa.   

Abstract

BACKGROUND: The prognostic impact of atrial fibrillation (AF) among patients at high risk for heart failure (HF) remains unclear. In addition, there is no risk estimation model for AF development in these patients.Methods and 
Results: The present study included 5,382 consecutive patients at high risk of HF enrolled in the CHART-2 Study (n=10,219). At enrollment, 1,217 (22.6%) had AF, and were characterized, as compared with non-AF patients, by higher age, lower estimated glomerular filtration rate, higher B-type natriuretic peptide (BNP) level and lower left ventricular ejection fraction. A total of 116 non-AF patients (2.8%) newly developed AF (new AF) during the median 3.1-year follow-up. AF at enrollment was associated with worse prognosis for both all-cause death and HF hospitalization (adjusted hazard ratio (aHR) 1.31, P=0.027 and aHR 1.74, P=0.001, for all-cause death and HF hospitalization, respectively) and new AF was associated with HF hospitalization (aHR 4.54, P<0.001). We developed a risk score with higher age, smoking, pulse pressure, lower eGFR, higher BNP, aortic valvular regurgitation, LV hypertrophy, and left atrial and ventricular dilatation on echocardiography, which effectively stratified the risk of AF development with excellent accuracy (AUC 0.76).
CONCLUSIONS: These results indicated that AF is associated with worse prognosis in patients at high risk of HF, and our new risk score may be useful to identify patients at high risk for AF onset.

Entities:  

Mesh:

Year:  2017        PMID: 28090009     DOI: 10.1253/circj.CJ-16-0759

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

1.  DNA methylation dysregulations in valvular atrial fibrillation.

Authors:  Kangjun Shen; Tao Tu; Zhaoshun Yuan; Jiangfeng Yi; Yangzhao Zhou; Xiaobo Liao; Qiming Liu; Xinmin Zhou
Journal:  Clin Cardiol       Date:  2017-08-28       Impact factor: 2.882

2.  Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation.

Authors:  Oscar Westin; Line Jee Hartmann Rasmussen; Ove Andersen; Eric Buch; Jesper Eugen- Olsen; Jens Friberg
Journal:  J Atr Fibrillation       Date:  2018-04-30

3.  Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure.

Authors:  Kotaro Nochioka; Satoshi Yasuda; Yasuhiko Sakata; Takashi Shiroto; Hideka Hayashi; Jun Takahashi; Hiroyuki Takahama; Satoshi Miyata; Hiroaki Shimokawa
Journal:  ESC Heart Fail       Date:  2022-04-17

4.  Pneumonia as a trigger for atrial fibrillation.

Authors:  Larry Nichols
Journal:  J Rural Med       Date:  2017-11-30

5.  Atrial Tissue Pro-Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B-Type Natriuretic Peptide.

Authors:  Chris J Watson; Nadezhda Glezeva; Stephen Horgan; Joe Gallagher; Dermot Phelan; Ken McDonald; Michael Tolan; John Baugh; Patrick Collier; Mark Ledwidge
Journal:  J Am Heart Assoc       Date:  2020-05-20       Impact factor: 5.501

6.  Clinical and Echocardiographic Predictors of Arrhythmias Detected With 24-Hour Holter Electrocardiography Among Hypertensive Heart Failure Patients in Nigeria.

Authors:  Tuoyo Omasan Mene-Afejuku; Michael Olabode Balogun; Anthony Olubunmi Akintomide; Rasaaq Ayodele Adebayo; Olufemi Eyitayo Ajayi; Valentine N Amadi; Omolola Abiodun Oketona; Amanze Nkemjika Ikwu; Bamidele Mene-Afejuku; Olaniyi James Bamikole
Journal:  Clin Med Insights Cardiol       Date:  2017-12-10

7.  Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART-2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study.

Authors:  Takuya Oikawa; Yasuhiko Sakata; Kotaro Nochioka; Masanobu Miura; Kanako Tsuji; Takeo Onose; Ruri Abe; Shintaro Kasahara; Masayuki Sato; Takashi Shiroto; Jun Takahashi; Satoshi Miyata; Hiroaki Shimokawa
Journal:  J Am Heart Assoc       Date:  2018-03-14       Impact factor: 5.501

8.  H2 FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors.

Authors:  Satoru Suzuki; Koichi Kaikita; Eiichiro Yamamoto; Daisuke Sueta; Masahiro Yamamoto; Masanobu Ishii; Miwa Ito; Koichiro Fujisue; Hisanori Kanazawa; Satoshi Araki; Yuichiro Arima; Seiji Takashio; Hiroki Usuku; Taishi Nakamura; Kenji Sakamoto; Yasuhiro Izumiya; Hirofumi Soejima; Hiroaki Kawano; Hideaki Jinnouchi; Kunihiko Matsui; Kenichi Tsujita
Journal:  ESC Heart Fail       Date:  2020-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.